STEVENS CAPITAL MANAGEMENT LP - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 86 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2014. The put-call ratio across all filers is 1.76 and the average weighting 1.0%.

Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2015$35,000
-58.8%
15,766
-63.8%
0.00%
-66.7%
Q1 2015$85,000
-49.1%
43,591
-30.9%
0.00%
-50.0%
Q4 2014$167,000
-30.7%
63,123
-21.0%
0.01%
-14.3%
Q3 2014$241,000
-31.3%
79,927
-7.0%
0.01%
-22.2%
Q2 2014$351,000
+663.0%
85,937
+703.0%
0.01%
+800.0%
Q1 2014$46,000
-47.7%
10,702
-36.3%
0.00%
-66.7%
Q4 2013$88,000
+31.3%
16,802
+58.5%
0.00%
+50.0%
Q3 2013$67,00010,6010.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q4 2014
NameSharesValueWeighting ↓
CAXTON CORP 37,069,140$64,500,00087.00%
ARMISTICE CAPITAL, LLC 2,000,000$3,480,0001.19%
IRONWOOD INVESTMENT MANAGEMENT LLC 432,259$752,0000.28%
Geller Advisors LLC 187,323$326,0000.21%
CAXTON CORP 57,000$99,0000.13%
Verity Asset Management, Inc. 64,476$112,0000.11%
TFS CAPITAL LLC 367,364$639,0000.06%
Cutler Capital Management, LLC 72,500$126,0000.06%
LUCAS CAPITAL MANAGEMENT 21,100$37,0000.02%
Nine Chapters Capital Management LLC 129,700$226,0000.02%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders